Intensive insulin therapy in severely burned pediatric patients: A Prospective randomized trial

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 3, 2010, Pages 351-359

  Jeschke, Marc G ^a,b   Kulp, Gabriela A ^a,b   Kraft, Robert ^a,b   Finnerty, Celeste C ^a,b   Mlcak, Ron ^a,b   Lee, Jong O ^a,b   Herndon, David N ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Burn; Insulin; Morbidity; Pediatric; Sepsis

Indexed keywords

ACUTE PHASE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; OXANDROLONE; PROPRANOLOL; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; CREATININE; HAPTOGLOBIN; PREALBUMIN; RETINOL BINDING PROTEIN; TRANSFERRIN;

ARTICLE; BODY SURFACE; BURN; BURN PATIENT; CALORIMETRY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DENVER DEVELOPMENTAL SCREENING TEST; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INFECTION; INFLAMMATION; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEPSIS; ULTRASOUND; BLOOD; BODY COMPOSITION; BONE DENSITY; HYPERGLYCEMIA; HYPOGLYCEMIA; INJURY SCALE; METABOLISM; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; UREA NITROGEN BLOOD LEVEL; WOUND INFECTION;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ALPHA-MACROGLOBULINS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY COMPOSITION; BONE DENSITY; BURNS; C-REACTIVE PROTEIN; CHILD; COMPLEMENT C3; CREATININE; FEMALE; HAPTOGLOBINS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MULTIPLE ORGAN FAILURE; PREALBUMIN; PROSPECTIVE STUDIES; RETINOL-BINDING PROTEINS; SEPSIS; TRANSFERRIN; TRAUMA SEVERITY INDICES; WOUND INFECTION;

EID: 77956623049     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201002-0190OC     Document Type: Article

References (61)

1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
2. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
3. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009;373:547-556.
4. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006;55:1096-1105. (Pubitemid 44100187)
5. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006;27:2716-2724.
6. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047. (Pubitemid 37430587)
7. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007;35:S503-S507.
8. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.
9. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
10. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN. Pathophysiologic response to severe burn injury. Ann Surg 2008;248:387-401.
11. Gore DC, Ferrando A, Barnett J, Wolf SE, Desai M, Herndon DN, Goodwin C, Wolfe RR. Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma 2000;49:673-678.
12. Wolfe RR, Miller HI, Spitzer JJ. Glucose and lactate kinetics in burn shock. Am J Physiol 1977;232:E415-E418.
13. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001;51:540-544. (Pubitemid 33009642)
14. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002;30:2438-2442.
15. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery 2008;144:629-637.
16. Hart DW, Wolf SE, Chinkes DL, Gore DC, Mlcak RP, Beauford RB, Obeng MK, Lal S, Gold WF, Wolfe RR, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000;232:455-465.
17. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Ferrando AA, Wolfe RR, Herndon DN. Persistence of muscle catabolism after severe burn. Surgery 2000;128:312-319.
18. Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 2006;244:121-130.
19. Greenhalgh DG, Saffle JR, Holmes JH 4th, Gamelli RL, Palmieri TL, Horton JW, Tompkins RG, Traber DL, Mozingo DW, Deitch EA, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776-790.
20. Jeschke MG, Chinkes DL, Finnerty CC, Przkora R, Pereira CT, Herndon DN. Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med 2007;35:579-583. (Pubitemid 46148551)
21. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ III, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009;94:1656-1664.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
23. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002;25:2081-2087.
24. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470. (Pubitemid 29418240)
25. Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004;89:1096-1101. (Pubitemid 38368396)
26. Przkora R, Barrow RE, Jeschke MG, Suman OE, Celis M, Sanford AP, Chinkes DL, Mlcak RP, Herndon DN. Body composition changes with time in pediatric burn patients. J Trauma 2006;60:968-971. (Pubitemid 43778623)
27. Przkora R, Jeschke MG, Barrow RE, Suman OE, Meyer WJ, Finnerty CC, Sanford AP, Lee J, Chinkes DL, Mlcak RP, et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg 2005;242:384-391.
28. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007;246:351-362.
29. Jeschke MG, Mlcak RP, Finnerty CC, Norbury WB, Kulp GA, Herndon DN. Burn size determines the inflammatory and hypermetabolic response. Crit Care 2007;11:R90.
30. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG. Cytokine expression profile over time in severely burned pediatric patients. Shock 2006;26:13-19.
31. Barrow RE, Mlcak R, Barrow LN, Hawkins HK. Increased liver weights in severely burned children: Comparison of ultrasound and autopsy measurements. Burns 2004;30:565-568.
32. Jeschke MG, Micak RP, Finnerty CC, Herndon DN. Changes in liver function and size after a severe thermal injury. Shock 2007;28:172-177.
33. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
34. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999;229:11-18.
35. Pierre EJ, Barrow RE, Hawkins HK, Nguyen TT, Sakurai Y, Desai M, Wolfe RR, Herndon DN. Effects of insulin on wound healing. J Trauma 1998;44:342-345.
36. Thomas SJ, Morimoto K, Herndon DN, Ferrando AA, Wolfe RR, Klein D, Wolf SE. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002;132:341-347. (Pubitemid 35024782)
37. Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin would and muscle. Am J Physiol 1999;276:E712-E720.
38. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004;145:4084-4093. (Pubitemid 39120556)
39. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004;239:553-560. (Pubitemid 38372772)
40. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005;42:870-879. (Pubitemid 40693204)
41. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004;240:340-349.
42. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma 2005;59:1148-1154.
43. Gauglitz GG, Toliver-Kinsky TE, Williams FN, Song J, Cui W, Herndon DN, Jeschke MG. Insulin increases resistance to burn wound infection-associated sepsis. Crit Care Med 2010;38:202-208.
44. Jeschke MG, Einspanier R, Klein D, Jauch KW. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002;8:443-450.
45. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005;146:30-34.
46. Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr 2009;155:734-739.
47. Srinivasan V. Hyperglycemia in the pediatric intensive care unit: a few steps closer to sweetening the pot. Pediatr Crit Care Med 2008;9:231-233.
48. White MF. The insulin signalling system and the IRS proteins. Diabetologia 1997;40:S2-S17.
49. Kahn CR, White MF, Shoelson SE, Backer JM, Araki E, Cheatham B, Csermely P, Folli F, Goldstein BJ, Huertas P, et al. The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog Horm Res 1993;48:291-339.
50. Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001;24:588-597. (Pubitemid 32198431)
51. Gauglitz GG, Halder S, Boehning DF, Kulp GA, Herndon DN, Barral JM, Jeschke MG. Post-burn hepatic insulin resistance is associated with er stress. Shock 2009; (June):18 (epub ahead of print).
52. Gauglitz GG, Herndon DN, Jeschke MG. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res 2008;29:683-694.
53. Jeschke MG, Gauglitz GG, Song J, Kulp GA, Finnerty CC, Cox RA, Barral JM, Herndon DN, Boehning D. Calcium and ER stress mediate hepatic apoptosis after burn injury. J Cell Mol Med 2009;13:1857-1865.
54. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275:9047-9054.
55. Gauglitz GG, Song J, Herndon DN, Finnerty CC, Boehning DF, Barral JM, Jeschke MG. Characterization of the inflammatory response during acute and postacute phases after severe burn. Shock 2008;30:503-507.
56. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119.
57. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306:457-461. (Pubitemid 39372439)
58. Song J, Finnerty CC, Herndon DN, Boehning D, Jeschke MG. Severe burn-induced endoplasmic reticulum stress and hepatic damage in mice. Mol Med 2009;15:316-320.
59. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529.
60. Hampton RY. ER stress response: getting the UPR hand on misfolded proteins. Curr Biol 2000;10:R518-R521.
61. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000;101:451-454.